STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Energy
factory

Constellation Energy Secures Historic $1 Billion Nuclear Power Deal with U.S. Government

byLiliana Vida
January 2, 2025
in Energy, Large-Cap, Renewables
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Contracts to Supply Clean Energy to Federal Agencies for a Decade

Constellation Energy (CEG) has announced a groundbreaking agreement to supply nuclear-generated electricity to over 13 federal agencies, marking a $1 billion milestone in clean energy contracts. The deal, revealed Thursday, represents the largest procurement of its kind and signals a significant step in the federal government’s commitment to sustainable energy solutions.

Powering Federal Facilities with Clean Energy

Under the agreement with the U.S. General Services Administration (GSA), Constellation will deliver more than 10 million megawatt-hours of electricity over the next decade, starting April 25, 2025. The power supply will span 80 federal facilities located within the PJM Interconnection, a regional transmission network covering parts of 11 mid-Atlantic and Midwest states as well as Washington, D.C.

The agencies benefiting from the deal include prominent entities such as the U.S. Department of Transportation, the Federal Reserve Board of Governors, and the Army Corps of Engineers. Collectively, the energy supplied will be sufficient to power more than 1 million homes annually, according to GSA estimates.

Driving Nuclear Innovation and Reliability

The agreement provides Constellation, the largest operator of nuclear power plants in the U.S., with the financial leverage to modernize its existing infrastructure. The company plans to extend the operational licenses of its nuclear plants and invest in new equipment and technologies, increasing output by approximately 135 megawatts.

Joe Dominguez, President and CEO of Constellation, emphasized the long-term benefits of the deal:
“The investments we make as a result of this contract will keep these plants operating reliably for decades to come and put new, clean nuclear energy on the grid while making the best use of taxpayer dollars.”

Stability Amid Growing Demand

The GSA highlighted the agreement’s value in providing budgetary stability for federal agencies. With rising electricity demand from data centers and AI facilities, as well as uncertainty over future power costs, the fixed-rate 10-year contracts ensure predictable energy expenses for the government.

Robin Carnahan, GSA Administrator, praised the collaboration:
“This deal demonstrates how the federal government can join major corporate clean energy buyers in spurring new nuclear energy capacity and ensuring a reliable, affordable supply of clean energy for everyone.”

This historic agreement underscores the vital role of nuclear power in the transition to sustainable energy, setting a benchmark for clean energy procurement across both public and private sectors.

You might like this article:Tesla Cybertruck Fire Outside Trump Hotel Las Vegas Leaves One Dead, Sparks Terrorism Concerns

Tags: CEGConstellation EnergyGrowthMoversNewsStock MarketUS Government
Previous Post

Tesla Cybertruck Fire Outside Trump Hotel Las Vegas Leaves One Dead, Sparks Terrorism Concerns

Next Post

GM Delivers Strong 2024 Sales, Fueled by EV Growth and Segment Leadership

Related Posts

Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock

byLuca Blaumann
August 7, 2025
0

Zepbound and Mounjaro Drive U.S. Sales, Yet Orforglipron Trial Results Raise Investor Concerns Eli Lilly (LLY) delivered a solid second-quarter...

Tariffs Dull E.l.f. Beauty’s Shine Despite Beating Expectations

byLuca Blaumann
August 6, 2025
0

Cosmetics giant sees 30% profit drop as China duties weigh on bottom line, even as revenue and product innovation remain...

trading-chart-2

Palantir Surges Past $1 Billion Quarterly Revenue, Lifts Guidance Amid AI Boom

byLiliana Vida
August 4, 2025
0

AI-driven growth, strong U.S. contracts, and Trump’s cost-cutting push propel Palantir into the top 10 U.S. tech companies by market...

Next Post
ev-charging-2

GM Delivers Strong 2024 Sales, Fueled by EV Growth and Segment Leadership

Latest News

Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock

Daxor’s New Handheld Blood Volume Analyzer Gets FDA Green Light

Tariffs Dull E.l.f. Beauty’s Shine Despite Beating Expectations

Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast

Palantir Surges Past $1 Billion Quarterly Revenue, Lifts Guidance Amid AI Boom

Based on Your Interest

tesla
Artificial Intelligence

Tesla Board Approves $29 Billion Alternative Compensation Plan for Elon Musk

August 4, 2025
evtol
Aerospace & Defense

Blade Air Mobility Sells Rideshare Business to Joby Aviation for $125 Million

August 4, 2025
trading-chart-2
Large-Cap

Qualcomm Posts Strong Q3 Results, Fueled by Automotive and IoT Growth

July 30, 2025

Recommended

Aerospace & Defense

Palo Alto Networks Eyes $20B Deal for CyberArk

July 29, 2025
Ecommerece

AMD and Amazon: Two Titans Poised for Explosive Growth

July 28, 2025
Entertainment

FCC Approves $8B Paramount-Skydance Merger Amid Political Controversy

July 25, 2025
Aerospace & Defense

FAA Keeps Boeing 737 MAX Production Cap in Place Amid Ongoing Oversight

July 24, 2025
Large-Cap

Intel Beats on Revenue, Misses on Earnings; Cuts Workforce by 15%

July 24, 2025
Stoxpo

Follow us on social media:

Highlights

  • Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock
  • Daxor’s New Handheld Blood Volume Analyzer Gets FDA Green Light
  • Tariffs Dull E.l.f. Beauty’s Shine Despite Beating Expectations
  • Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast
  • Palantir Surges Past $1 Billion Quarterly Revenue, Lifts Guidance Amid AI Boom

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock

August 7, 2025

Daxor’s New Handheld Blood Volume Analyzer Gets FDA Green Light

August 7, 2025

Tariffs Dull E.l.f. Beauty’s Shine Despite Beating Expectations

August 6, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?